| __timestamp | TG Therapeutics, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 10811000 |
| Thursday, January 1, 2015 | 19886580 | 33001000 |
| Friday, January 1, 2016 | 12631689 | 64936000 |
| Sunday, January 1, 2017 | 21977998 | 99909000 |
| Monday, January 1, 2018 | 20759000 | 127724000 |
| Tuesday, January 1, 2019 | 20838000 | 161524000 |
| Wednesday, January 1, 2020 | 121812000 | 182933000 |
| Friday, January 1, 2021 | 152137000 | 219982000 |
| Saturday, January 1, 2022 | 83231000 | 278139000 |
| Sunday, January 1, 2023 | 122706000 | 309799000 |
Unleashing insights
In the dynamic world of biotechnology, understanding financial trends is crucial. Over the past decade, TG Therapeutics, Inc. and Ultragenyx Pharmaceutical Inc. have showcased distinct patterns in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Ultragenyx's SG&A expenses surged by nearly 2,800%, peaking in 2023. In contrast, TG Therapeutics experienced a more modest increase of approximately 400% over the same period.
While both companies have seen growth, Ultragenyx's aggressive expansion strategy is evident in its spending, which consistently outpaced TG Therapeutics. Notably, in 2023, Ultragenyx's SG&A expenses were nearly 2.5 times higher than those of TG Therapeutics. This divergence highlights differing strategic priorities, with Ultragenyx potentially focusing more on scaling operations. As the biotech sector continues to evolve, these spending patterns offer valuable insights into each company's strategic direction.
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.
argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Ultragenyx Pharmaceutical Inc.
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.